“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...

Please provide your email address to receive an email when new articles are posted on . Although we use all of the modern presbyopic IOLs In our practice, two lens types now dominate our presbyopic ...

Please provide your email address to receive an email when new articles are posted on . Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, ...

(RTTNews) - Alcon, a division of Novartis, reported new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens compared to the ZEISS AT ...

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,† Clareon PanOptix Pro provides more uninterrupted ...